An in vitro study suggested that the anti-U1 RNP antibody extracted from CTD patients could bind with human pulmonary arterial endothelial cell (HPAEC) and directly recognize a variety of antigens on its surface, being a possible trigger of endothelial cell inflammation of CTD-PAH [39]. This evidence concerns the gene U1 and pulmonary arterial hypertension.